Qi Diagnostics and NasDaq-listed Avalon GloboCare Signed Agreement to Enter Diabetes Reversal and Weight Management Markets in The U.S. and European Regions
(Hong Kong, 14 April 2023) Qi Diagnostics Limited, a developer of innovative gas nanosensor technology and in vitro breath diagnostic devices, has announced that it has signed a memorandum of understanding (MOU) with Avalon GloboCare Corp. (NASDAQ: ALBT). Under the terms… Read More »Qi Diagnostics and NasDaq-listed Avalon GloboCare Signed Agreement to Enter Diabetes Reversal and Weight Management Markets in The U.S. and European Regions
English 
Chinese